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For those of us who are set in our ways, we must first seek to understand that we 
may not grasp everything. Through my life, I have found that the best way to 
approach any situation or circumstance is to not have pre-conceived notions 
about more than we can see with the naked eye. Addiction poses a strong 
negative stigma, because most people see it as a choice. My personal journey 
through drug addiction counseling has undoubtedly changed the way I empathize 
with people and has inspired me to instill this transition in others. 
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Process Analysis 
The completion of my thesis took place in several stages. I underwent a process 
that allowed me to compile the most relevant information and reflective reasoning that 
conveyed my purpose to an audience. I started with a general idea, re-sulting from an 
influential internship I had in the summer of 2017. I worked at a partial hospitalization 
and drug rehabilitation facility and encountered a population of people I never knew 
could make such an impact on my life. I learned about a position opening for a COCA 
(chemical dependency counselor assistant) phase I, in which I could interact with the 
patients, take vitals, administer Breathalyzer tests, perform urine drug screenings, assist 
with medications, and monitor ongoing drug use. I completed a forty hour online course 
which certified me as a COCA phase I for one full year, applied for the position, and got 
an amazing internship opportunity. As a biology major on a pre-physician assistant 
track, this internship was in pursuit of my "patient-care hours" for applying to Physician 
Assistant programs. It was within my first few shifts at work when I realized that this job 
would bring me much more than I had initially intended, and offered a lot more to me 
personally than just fulfilling my "patient-care hours." 
I was raised in a Catholic, conservative household, with little acceptance or 
tolerance for immense struggles, straying form the norm, or failure. This attitude has 
brought me a sense of strong work ethic and passion ; however, it did not necessarily 
prepare me to have an open mindset to the diverse and sometimes struggling world at 
large. As I embarked on my summer adventure with several misconceptions about drug 
addicted persons, I can say that I left enlightened with a new empathy I had never felt 
before. It was then that I knew that the stigma associated with people who struggle from 
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addiction should be changed and could be addressed with widespread education and 
increased knowledge of the subject. With a clear understanding that people must take 
responsibility for their actions and wrong doings, we as a society also need to better 
understand addiction , what transpires in addicts' life to have them end up where they 
do, and the true burden they carry every day and the complexities of getting clean. It is 
so imperative to put ourselves in someone else's mental, biological, and environmental 
state of life, and then reflect on how we might respond to those same stimuli. This 
summer, I recognized that this is nearly impossible to do unless we are educated and 
walk a day in their shoes. 
Furthermore, I was also lucky enough to take an abnormal psychology course 
this past fall , which was perfect timing for my project. It also helped me meet an 
outstanding professor, Niloufar Assar, who has become a great help to me on this 
project. Abnormal Psychology studies individuals who are "abnormal" or "atypical" 
compared to the members of a given society. During this course, we delved into 
stigmatization which gave us a deeper understanding of it. Our class discussed mental 
health and the predispositions that may lead a person down a path of addiction. We 
examined the thoughts, behaviors, and actions cif drug-addicted persons, what family or 
childhood backgrounds may have introduced a pathway to drug addiction, and how 
difficult it is to rise out of that situation. Then we assessed how these individuals are 
viewed by society, and why it is so difficult for the societal norm to empathize with drug 
addicts, let alone tolerate them. It seemed that I had an extraordinary interest in this 
topic when we began these dialogues, more so than my peers in the class. Perhaps my 
extreme passion came mainly from my previous work experience, but I could not let it 
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go. I saw this as a sign to expand my knowledge in this area and to focus more closely 
on the intricacies of this dilemma. 
With the inspiration from my internship along with the influence of my abnormal 
psychology class, I had a genuine desire to learn more about this area. Therefore, I 
have assembled a two-part thesis; part one is a compilation of research on drug 
addiction and the second part is the reflective portion. I was able to work with my 
Abnormal Psychology professor, Niloufar Assar, to assist me with the research and 
organizational methods of my paper, and I was accepted into Honors 499, the Senior 
Honors Project class, with Jason Powell as my advisor to help me with the philosophical 
and reflection portion of my thesis. They have both provided me with more guidance 
and more support than I would have expected. 
I began my thesis by setting a specific outline to follow. I later recognized that my 
original outline put a specific limit on my research, and that for my thesis, I was better 
off considering more information than less. Professor Assar was extremely helpful 
throughout this process. She directed me to various useful databases, journal articles, 
and was a great resource for diverse textbook material. After a long, rather intense 
process, I pinpointed and concentrated on a few main topics of interest that I felt could 
lower the stigma of drug-addicted persons: addiction as a disease and not a choice, 
biological risk factors that can contribute to drug addiction, environmental risk factors 
that can contribute to drug addiction, mental illness as a precursor to drug addiction, 
and controversial treatments for drug addiction. My goal was to address the biggest 
misconceptions surrounding the disease and treatment phase of addiction. The idea 
that judging someone for their current situation is not helping them, is a key point I 
Main 4 
stress throughout my thesis. Before the writing process, I identified the crucial points of 
~ 
the research, and then I began to organize my information. After completing this 
organizational step, I wrote my introduction which I found it was best to write towar-d the 
end of my writing process so that I could accurately depict what I covered through the 
entire paper. 
As a part of my ongoing research , thesis formulation, and a continuation for my 
desire to help those drug-addicted individuals, I completed thirty hours of additional 
training and received my certification for my COCA phase II. This allows me to legally 
continu·e my work in rehabilitation facilities, expand my areas of influence in that work, 
and it gives me the option to keep up my certification with additional continuing 
education every two years. I felt the need to not only inform readers about the 
importance of lowering the stigma of drug-addicted persons, but also to personally 
contribute my knowledge and talents to this community. In the follow-up reflection 
portion of my thesis, I shared my journey through my summer internship of 2017. I also 
discussed my summer work plans for 2018 in which I will be utilizing my COCA phase II 
licensure to work at a new rehabilitation facility as a behavioral therapist. 
The process for developing my thesis was a great self-learning and reflective 
process. I was able to recognize the manner in which I approach large undertakings, 
and how best to assess what went well and what could be improved. I think it is 
important to note that being in the Honors 499 class was an enormous benefit. First, it 
provided an outstanding professor. I could not have asked for a better instructor, advisor 
or motivator. Jason is a great leader, encouraged all of us to go above and beyond, 
think differently, and truly made us excited about our specific projects. He offered such 
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thoughtful insight which added dimensions to my project that I had not considered. The 
class also provided me with a schedule, and required me to have firm work ·times in 
order to stay on track with my project. It also taught me that I find it extremely helpful to 
have other people holding me accountable for my actions. Structure was a crucial 
element for me throughout this process. I also truly enjoyed having weekly discussions 
with my classmates on where they were in the process, how they were feeling, and 
what obstacles they were facing with their projects. It helped me knowing that a group of 
us were all in this together, as we supported each other throughout. 
The hardest part of the process involved my research method. I designed my 
outline with a very specific path of research, and came to learn that it was not in sync 
with my original thoughts. For example, I assumed that drinking contributed to an onset 
of drug abuse, but in reality research showed that it had no correlation. However, 
nicotine use did. I outlined my paper based on assumptions I had made before the 
research process. This caught me off guard and had me doubting myself Even when I 
felt that I had a decent handle on my research , I found myself switching back and forth 
from general to specific, which made my research not as cohesive as I would have 
liked . It was extremely helpful when I received my first set of feedback from Professor 
Assar along with a new book recommendation. This information really helped me tie 
together my research and reflective piece. 
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The Negative Stigma Surrounding Drug Addicted Persons 
I believe that the negative stigma surrounding people who struggle with addiction 
and/or substance abuse is due to a lack of knowledge regarding the reality, onset, and 
treatment of this illness. I will justify this by first defining and informing readers about 
addiction as a disease, I will then undercover several risk factors and predispositions to 
substance use, and finally I will explore some of the controversial treatment options for 
drug addicted persons and substance abusers. Throughout this paper, I will address 
several common fallacies associated with drug addiction in attempt to inform the public 
about the truth these people face. After the research portion, I will reflect on the steps I 
have taken to help these people that have impacted me, and my opinion of this topic on 
a more personal level. 
Drug Addiction as a Disease 
From an outsider's perspective, addiction can simply look like a lack of will power 
or motivation. What people need to better understand is that addiction involves 
physically altering the pathways of the brain (SAHMSA, Walsh). As defined by the 
Substance Abuse and Mental Health Services Administration (SAHMSA), "a substance 
use disorder, or a drug use disorder, is characterized by being a mild , moderate, or 
severe dependence on certain drugs or prescription medications. This transpires as the 
continual use of a drug produces substantial damage to the user (SAHMSA, Lynsen). " 
The latest DSM- 5 criteria for a Substance Use Disorder (SUD) is a problematic pattern 
of use that impairs functioning resulting with two or more of the following symptoms: 
within a one year period: failure to meet obligations, repeated use jn situations where it 
physically is dangerous, repeated relationship problems, continued use despite 
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problems caused by the substance, tolerance, withdrawal, substance taken for a longer 
time in greater amounts than intended, efforts to reduce or control use to not work, 
much time spent trying to obtain the substance, social hobbies or work activities given 
up or reduces, and craving to use the substance is strong (Kring 281 ). A use 
disorder/dependence can be present without addiction , but, if someone is suffering from 
addiction, they more likely than not, experience dependence as well (SAHMSA, Walsh). 
Dependence, different than addiction, occurs when the brain has rewired itself to 
a point where the person can only function normally when on that drug. The American 
Society of Addiction Medicine expresses addiction as a "chronic disease of brain 
reward, motivation, memory, and related circuitry (SAHMSA, Walsh). " Stedman's 
medical dictionary terms disease as, "an interruption, cessation, or disorder of body 
function , system, or organ (Prus 141)." Diseases are known to destructively alter 
physiological processes in the human body. In a very similar way, drug abuse disrupts 
neurobiological processes in the brain. This intensifies addictive behaviors, ultimately 
producing a vicious cycle. As addiction is a definite disease, it must be established how 
abuse of a certain drug effects a person's well being. Drug abuse causes the brain to 
exceed natural dopamine levels or alter the activity of the dopamine pathways. 
Nevertheless, the brain becomes impacted in a manner that alters the way a person 
thinks about a particular drug (Prus 141 ). It should be noted that different classifications 
of drugs affect the normal functions of the brain via slightly altered mechanisms. 
Parts of the Brain Affected by Continual Drug Use 
Chronic use of a drug eventually alters the way the body responds it. A few key 
terms involving the psychological and physiological adaptations of a person's body 
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alongside chronic drug use are tolerance, sensitization, and dependence. Different 
drugs and the extent to which one uses them, can lead to these various situations. 
Tolerance, behavioral and pharmlogical, serves a reduction in the body's response to 
that drug. Meaning, a person must take more and more of the drug to achieve the 
desired feeling. Sensitization, however, is an increase in the responsiveness to a 
particular drug after prolonged use. Dependence, as stated before, is the physical and 
emotional need to use a drug to simply feel "normal." Without the drug, the body will 
initiate withdrawal (Prus 130). 
Addiction is never "cured". It is something people struggle with on a daily basis, 
and the longer a person uses, the more they can be affected. Recurrent drug use 
physically alters the pathways of the brain that make the desire of a drug more than just 
a motivational problem. Under frequent administration of a drug, the amygdala and 
hypothalamus alter the natural brain processes to that of the drug. This .is where 
dependence transpires (Prus 156). The amygdala is a part of the brain that is largely 
associated with emotions and memory. It is directly affected by the stimuli received 
during traumatic or euphoric events. As illicit drug use proceeds, the amygdala 
communicates these feelings and retentions to the thalamus and prefrontal cortex. 
These areas are in control of steering sensory information to the cerebral cortex, as well 
as initiating stimuli and motor responses (Prus 154). The hippocampus is a portion of 
the brain that links the feelings undergone from the thalamo-cortico-amygdala pathway 
to an environmental situation. In the context of a drug addict, these desired emotions 
felt by a certain drug can be directly associated with a part of town , group of people, or 
even a person's name that connects him or her to that drug (Prus 158). 
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Frequent Illicit drug use instigates an altered production of sensory inputs and 
outputs in the brain. When a person stops the use of a drug, the autonomic system 
becomes disrupted. A person will undergo physical withdrawal symptoms without use of 
the drug. These can manifest as excessive sweating, low heart rate, nausea and 
vomiting, heavy breathing, and many more flu like symptoms. As physical withdrawal 
occurs, the amygdala reduces the activity of dopamine neurons, which ultimately 
eliminates rewarding effects in general. This puts a person in a state known as 
anhedonia, which is a psychological form of withdrawal (Prus 156). The dorsolateral 
prefrontal cortex is the area of the brain that manages impulse control. Recurrent use of 
illicit drugs damages this portion of the brain, making it more feasible for a drug addict to 
pursue short immediate gratification instead of healthy long-term satisfaction (Prus 156). 
So, how exactly does addiction take its course in the human brain? There are 
three main stages of addiction: Intoxication, Developmental of Dependence During 
Chronic Use, and the Pre-occupational and Anticipation stage. Each of the stages 
affects regions of the brain that make it harder and harder to avoid a particular drug. 
The Intoxication phase directly connects to the reward pathway in the brain (Prus 157). 
A highly regarded theory involving the reward pathway is referred to as the incentive-
sensitization theory. This theory is implemented first in the intoxication phase due to the 
"liking" of a particular drug. The liking comes from the good feelings activated by the 
dopamine receptors in the brain that makes you feel good in presence of a particular 
drug. These intense rewarding effects are enough for the human brain to seek pleasure 
via the drug over and over (Kring 306). In the stage of Developmental of Dependence 
During Chronic Use the amygdala has been affected to point of a shifted motivation to 
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use (Prus 157). Following the incentive:..sensitization theory, this stage of addiction 
initiates the "wanting" of a drug. This is different than the liking because at this point, the 
body now craves the drug (Kring 306). The desire to use becomes a new combination 
of avoidance of withdrawal symptoms as well as seeking the drugs gratifying effects. In 
the Pre-occupational and Anticipation stage, or the final phase of addiction, many more 
areas of the brain play a role. The person has now become completely consumed with 
pursuing the drug. The hippocampus, the portion of the brain that ascribes significance 
to received stimuli, becomes prominently involved. At this point, there is now 
communication between the reward pathway, learning systems, amygdala, and 
hippocampus. In addition, changes in the prefrontal cortex have affected decision 
making. Due to the changes in the brain, a person is now hardly able to focus on 
anything but that drug (Prus 158). Likewise, the incentive-sensitization theory states 
that over longer periods of time, the "liking" for a drug decreases, while the "wanting" 
increases. This shift can be attributed to the maintenance of addiction (Kring 306). 
Common Misconceptions Regarding Addiction 
Addiction and substance use disorders are made apparent to the general public 
as serious health problems, an incapacity to perform normal tasks, and failure to meet 
key responsibilities at a place of obligation (SAHMSA, Lynsen). There are several 
substance use .disorders prevalent in our society, which include: Tobacco Use disorder, 
Hallucinogen Use disorder, Opioid use disorder, cannabis use disorder, Alcohol use 
disorder, and many more (SAHMSA, Walsh) . It is important to understand that the 
decision to take an illicit drug is in the hands of the user, but continual use is in the 
hands of his or her rewired brain. However, even looking at the initial choice to start 
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using a drug, we must consider the risk factors involved. Just as a pathogen 
encompasses certain vulnerabilities to a host, so does addiction (Prus). 
It is frequently thought that substance use disorders occur most commonly in 
older individuals who are prescribed several medications due to frequent health 
problems. This is usually assumed because these people are used to taking drugs in 
·general. In actuality, this is not the case. Substance use disorder manifests itself in all 
ages, ethnicities, health scales, and economical classes. SAHMSA indicates, "In 2014, 
about 21.5 million Americans ages 12 and older (8.1 %) were classified with a substance 
use disorder in the past year. Of those, 2.6 million had problems with both alcohol and 
drugs, 4.5 million had problems with drugs but not alcohol, and 14.4 million had 
problems with alcohol only (SAHMSA, Lynsen)." 
Correlations Between Drug Abus? and Other Factors 
Studies have shown that drug abusers tend to show common personality 
characteristics that could have been implemented by genetic and/or environmental 
factors. These features include the inability to control emotions such as rage, shame, 
jealousy, and anxiety. Other factors include a lack of responsibility, a scarcity of 
cautiousness, and deficiency of independence. Resistant of authority, narcissistic, 
resentful , and confusion over sex roles are all tendencies drug users commonly 
possess. Environmentally, the surroundings of drug users also show correlation 
-regarding peer rejection and parent neglect (Marion and Willard , "Biological and 
Psychological Reasons for Substance Abuse"). Furthermore, abuse at any capacity 
can serve as a vulnerability contributor to drug use in general, but severe physical 
- . 
childhood abuse shows an associated risk for earlier onset (Darke and Torok). 
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In a particular study conducted in Australia, susceptibility to drug abuse was 
observed. Individuals with less than ten years of education proved to be four times more 
likely to experience drug abuse. Depression, short temper, and aggressiveness in 
association to shyness were also found to be significant risk factors. Drug abuse also 
proved to be more likely in individuals who felt dominated by their friends and were 
pressured to try drugs by their peers. In contrast to what many people believe, 
socioeconomic status, cast status, sexual contact and alcohol use in the past month 
showed a negative relationship to drug abuse. However, nicotine dependence showed a 
convincing correlation (Niraula). This is most likely due to the fact that the brain has 
been altered into a dependent state via nicotine, but not necessarily from alcohol in a 
short time frame. This state of dependence increases the likelihood of drug abuse. 
Biological vs. Environmental 
Why does one become an alcoholic? How do people get addicted? Is it because 
their parents are? Or because they grew up around drugs an alcohol their entire life, 
and that is all they know? The constant question regarding the destructive life path 
taken by substance abusers is nature versus nurture. Both features possess influences 
on the user, and need to be better understood by society. 
The predispositions to substance use disorders are not solely based on genetic 
or environmental factors, but rather a combination of both. The extent to which one is 
abusing drugs also increases with a mixture of these two considerations. Aside from risk 
factors known to increase likelihood of substance use disorders, drugs also carry 
addictive underlining properties that are prone to sustain drug use and dependence 
(Marion and Willard, "Biological and Psychological Reasons for Substance Abuse"). 
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Studies have found that in the earlier stages of substance use, environment 
plays a larger role than biologic. This is due to the fact that adolescents do not have 
much freedom to express their genetic characteristics while under common authorities. 
With less parental monitoring, however, genetic factors have a higher likelihood of 
manifesting sooner. Moreover, later stages of use are more induced by genetic factors 
because of the freedom and opportunity that comes with age. Nevertheless, it should be 
noted that some studies have observed drug abuse in people later in life, even when 
surrounded with strong environmental values in their youth (Meyers and Dick). This 
goes to show; drug abuse cannot be attributed to one specific environment. 
Biologically, there is no one specific gene that makes someone a drug user. 
Nonetheless, there are several genes with indirect properties that can combine to 
increase a vulnerability to certain behaviors and disorders. These genetic 
predispositions along with specific upbringings can increase the likelihood of substance 
use disorders (Meyers and Dick). Developmental endophenotypes are biological genetic 
contributions to a specific person and explain how it can influence behavioral effects 
and clinical disorders. Asians, for example, have a lower frequency of alcohol problems 
compared to other ethnicities; this can be attributed to their physiological intolerance. 
Mutations in genes that code for alcohol dehydrogenase (ADH) are present in about 
three fourths of Asians, in which their body cannot tolerate excessive amounts of 
alcohol, which in turn can serve a protection from alcohol dependence (Kring 304). In 
another case, studies have shown that the heritable endophenotype P3AR serves as a 
risk factor for adolescents misusing substances (Iacono and Malone). Research has 
also correlated variations in the CYP2A6 gene, a gene that controls the metabolization 
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of nicotine, to the likelihood of smoking more (Kring 304). These are just a few 
uncontrollable genetic factors that, but can contribute to a problem people often see as 
controllable. 
Mental Disorders 
Mental disorders have also been proven to be associated with an increased risk 
of substance abuse. It is important to note that this increased disposition could have 
partly to do with the shared etiology factors of mental disorders and the onset of drug 
abuse. Regardless, the combination of behavioral disorders along with previous 
substance use has proven to be the clearest forecaster for the result of substance use 
disorder. Some behavioral disorders have conveyed a greater association to drug 
abuse than others. For example, bipolar disorder, panic disorder, social and specific 
phobias, posttraumatic stress disorder, and separation anxiety were all strong predictors 
of some type of substance dependence, while agoraphobia and generalized anxiety 
disorder showed no assoCiation do drug misuse (Swendsen). This could be due to the 
fact that agoraphobia and generalized anxiety disorder prevent people from facing their 
fears, while the other disorders are instill a sense of urgency that requires physical 
action. 
Pain, anxiety and depression are common among drug abusers. From a 
biological standpoint, health problems such as heart disease, diabetes and 
hypertension can commonly lead to diagnosable mental illness. Whether instigated by 
the user himself or herself, or a result of accidental physical trauma, health 
complications can have an indirect impact on substance abuse. With a diagnosis of a 
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behavioral disorder, the likelihood of substance abuse increases (Jamshid Ahmadi MD , 
Fatemeh Tabatabaee MD & Zahra Gozin MD). 
Uncontrollable traumatizing situations are also known to have serious 
consequences. For example, studies have shown that life events that cause post-
traumatic stress disorder, panic disorder, and high anxiety seem to be specifically 
disposed to the calming affects of alcohol. This increasing desire for internal peace and 
serenity, commonly leads to alcoholism. In another study, after controlling for the effects 
of those who abused substances prior to being assaulted, it was determined that newly 
assaulted women were more than twice as likely to abuse substances than non-
assaulted women (Kilpatrick). 
Medicated Assisted Treatment 
Medicated assisted treatment (MAT) is the combination of counseling therapies 
and prescribed medication in pursuit to control an addiction in the healthiest, most 
beneficial way possible (SAHMSA, Lynsen)." Studies have found that the combination 
of the right medication and psychotherapy prove to be the most beneficial way of 
treatment and relapse prevention for drug addiction (SAHMSA, Walsh). 
People have numerous misconceptions about Medicated Assisted Treatment for 
substance abusers. Several argue that introducing these new drugs creates an even 
higher risk for drug abuse in today's society. Some people feel that to be considered 
"abstinent from drug use" one must not be taking any controlled substances. These are 
common misunderstandings that need to be addressed in order to decrease the 
negative stigma associated with drug users and their road to recovery. 
Perhaps, one of the most controversial MAT treatments is that used to treat 
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Opiate Use Disorder (OUD). Methadone and buprenorphine are the two of the most 
commonly prescribed detoxification medications for OUD. Some people are against 
MAT because they argue that these new drugs can be abused and used for more harm 
than benefit like they are intended for. And, yes methadone and buprenorphine can be 
misused, like anything else. For those who are not addicted to opioids, these 
medications can cause euphoric effects. However, most data suggests that the misuse 
of these drugs occurs in the attempt to control cravings and withdrawal symptoms, not a 
motive to get high (NIDA "Misconceptions About Maintenance Treatment"). Even 
Naltrexone, which possesses no euphoric effects at all , can cause controversy. This is 
because some people, even drug abusers themselves, see reliance on another 
medication as not necessarily a full recovery or considered "sober living." What must be 
better understood is the efficacy of these medications while dealing with a life-
threatening illness. Several studies show an increase risk for relapse from those who 
follow their detoxification with abstinence. Although relapse should not be viewed as 
complete failure on the road to recovery, it can be very dangerous due to the amplified 
threat of a deadly overdose. This is why Medicated Assisted Treatment plays a crucial 
role in revering from drug dependence (NIDA, "Efficacy of Medications for Opioid Use 
Disorder"). 
Methadone 
Methadone (Dolophine) is a commonly use detoxification medication treatment 
that can be prescribed to addicts that aids in lessening and discontinuing the use of 
opiate medications (SAHMSA "Methadone"). A common dosage is approximately 60-
100 mg daily (Lobmaier). It can be taken in various forms such as liquids, wafers, or 
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pills (SAHMSA "Methadone"). It is not required of a patient to be detoxified of illicit drugs 
before methadone treatment. Methadone is considered a full-agonist due to its ability to 
obtain a maximum response from receptors. For this reason, it is typically given to those 
who are addicted to excessively high doses of opiates. Methadone works by rewiring 
the way the human-nervous system responds to pain, by blocking the positive effects 
felt from using an illicit opiate. A patient's willingness to take this medication also stems 
from methadone's ability to reduce the commonly feared withdrawal symptoms such as 
nausea, headaches, excessive sweating, and other flu like symptoms (SAHMSA 
"Methadone"). Methadone, notably, has a higher risk of overdose than buprenorphine, 
which is why precautions must be set in place (NIDA "Misconceptions About 
Maintenance Treatment"). 
To begin legal treatment with methadone the drug must be administered under 
the control of a physician and distributed through an Opioid Treatment Program (OPT). 
Methadone can be retrieved in public or private clinics, and based on insurance, with or 
without an out of pocket payment. Different clinics, offices, and treatment facilities vary 
slightly in their protocol and from patient to patient regarding the maintenance of 
methadone (SAHMSA "Methadone"). The first visit typically entails a screening in which 
patients are asked about previous drug use, medical history, and are possibly given 
drug tests. The goals and guidelines of the methadone clinic are also explained. 
Methadone treatment should be specifically dosed for each patient's needs, and 
generally accompanied by weekly counseling and group therapy (SAHMSA 
"Methadone"). Due to the negative stigma associated with methadone clinics, as the 
patient shows stable compliance and efficient outcomes with the medication, physicians 
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may allow the patient to self-administer the drug at home between frequent visits 
(Miller). Treatment with the use of methadone varies in length but typically last 
anywhere from 1 to several years. As treatment comes to an end, the patient must be 
slowly weaned off due to its addictive effects (SAHMSA "Methadone"). 
Methadone clinics generally have a negative sigma associated with them from 
both drug and non-drug users. People tend to consider it "illicit substance replacement." 
This is why several drug addicts, or family members of drug addicts either avoid or are 
extremely secretive about this type of treatment. Moreover, methadone clinics tend to 
be few and far between, residing in unfavorable locations. Aside from the factual 
benefits of this medication, the general public seems to be more focused on the 
negative connotations of the drug (Miller). 
Buprenorphine 
Buprenorphine is a medication that was approved for clinical use in 2002, and 
with the combination of naloxone, possesses a significantly decreased risk for misuse. 
(Lobmaier). While it lessens the physical effects of opioid craving and withdrawal 
symptoms, it also contains pharmacological properties that strengthen safety against 
overdose (SAHMSA, "Buprenophine"). When compared to a placebo, buprenorphine is 
found effective when given in medium to high dosages. A ceiling effect is achieved is 
buprenorphine at around 16 to 20 mg (Lobmaier). 
The access to this medication is also much greater than others. Buprenorphine is 
the first medication used to treat opioid dependency that can be prescribed and taken in 
a non-structured environment. So, for example, if methadone clinics are not readily 
available or desired by a patient, buprenorphine can serve a good alternative. Like most 
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other Medicated Assisted Treatments, buprenorphine is advised to be taken along with 
counseling and support groups (SAHMSA, "Buprenorphine"). 
A common issue with medication prescribed to treat drug addiction is the high 
risk for misuse. Like methadone, buprenorphine, by itself, can be abused, especially if 
injected. So, in recent years buprenorphine has been combined with the drug naloxone 
in a sublingual tablet to avoid the misuse. When taken sublingually, naloxone is not 
effective, but when injected, it eliminates the desired euphoric effects by drug users. 
This is why less supervision is needed when prescribed a buprenorphine-naloxone 
medication (Lobmaier). This decreased risk of misuse increases the likelihood of 
competency with the drug by the patient. Although buprenorphine has a lessened risk of 
maltreatment compared to other medicated treatments for opioid dependency, there is a 
definite risk for those who do not have an opioid dependence problem, because the 
drug does contain addictive properties (SAHMSA "Buprenorphine"). 
Buprenorphine is considered a partial opioid agonist because it does not give the 
patient a "high" but does provide them with limited euphoric effects that can only be 
noticed as reduction of withdrawal symptoms (NIDA "Misconceptions About 
Maintenance Treatment"). Buprenorphine binds to the opioid receptors, with a slow 
dissociation. This means that if the medication is taken before any other opioid receptor-
binding drug, the patient will not be able to feel the effects of that drug. This is why 
· buprenorphine provides a lower risk of overdosing from other opioids. However, if other 
opioids are taken before buprenorphine, buprenorphine can induce withdrawal 
(Lobmaier). 
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Buprenorphine medication assisted treatment occurs in three phases. The first 
phase is called the induction phase, and this is where the medication can be taken only 
when a patient has been undergoing withdrawal fro 12 to 24 hours. It is very important 
to not give a patient a medication containing buprenorphine if opioids are still in their 
system because this can increase withdrawal symptoms even more (SAHMSA 
"Buprenorphine") The second phase is termed, the stabilization phase. ThJs is when a 
patient has significantly reduced his or her use of an illicit opioid, no longer has cravings 
for the drug, and possesses minimal side effects. At this point, the dosage of the 
buprenorphine-containing drug may be tailored to the needs of the patient (SAHMSA 
"Buprenorphine"). The final phase is called the maintenance phase, and this is where a 
patient may stay forever, or could be placed into a medically supervised withdrawal. 
Withdrawal from buprenorphine is far less intense than that from an illicit opiate, but will, 
nevertheless need to be monitored (SAHMSA, Buprenorphine). 
Naltrexone 
Naltrexone is an opioid antagonist, meaning it blocks the opioid receptors in the 
brain without causing tolerance or withdrawal (NIDA, "How Do Medications to Treat 
Opioid Addiction Work?"). Like naloxone, naltrexone does have the capacity to reverse 
the side effects from an opioid overdose (Marion and Willard "Naltrexone"). Naltrexone 
not only decreases cravings associated with prior drug use, but also works to eliminate 
and reverse euphoric effects felt by drugs in general. So, if one were to use illicit drugs 
on this medication, they would not feel the desired effects. This makes the medication 
extremely useful for recovering addicts facing the temptations to relapse (Raber and 
Wien9law). The downside to this particular form of treatment therapy is that when it is 
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administered orally for opioid addiction, it is not well tolerated by most patients. 
Therefore, Naltrexone's effectiveness is debatable in its original pill form. However, in 
2010, Vivitrol, an injectable form of naltrexone commonly used to treat alcohol use 
disorder, was FDA approved to help treat opioid addiction (NIDA, "How Do Medications 
to Treat Opioid Addiction Work?"). 
It should be noted that Naltre~one is not a withdrawal management medication 
like buprenorphine and methadone. It cannot be given to current opioid dependent 
users. Vivitrol, specifically, is ideal for patients who have low access to medical care 
because the shot can sustain lasting effects for weeks (NIDA, "How Do Medications to 
Treat Opioid Addiction Work?"). Hence, a key factor regarding the success of 
naltrexone is the patient's compliance to take it. 
Concluding Thoughts 
It had been thought for several years that addiction expressed itself in selfish , 
pleasure-seeking, and merely just bad people, as opposed to mentally and physically 
suffering beings. After recent years of research and studies, addiction has been 
classified as chronic and progressive disease of the brain (O'Leary). As a society, we 
must seek to learn and understand more about the subjects we choose to judge. A 
simple lack of knowledge can be the root of evil in our world today. Drug addiction is a 
hard concept for people to fully grasp, especially when they do not understand the 
entire process. In no way should people be excused for their wrongful thoughts, actions, 
or behaviors while suffering from addiction , but, to fully blame and think poorly of them 
for their problem is not right either. Addiction is the true culprit, and instead of 
. associating drug users with ignorance and disgrace to society, we must seek to find an 
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empathetic side of ourselves to want to help. Given the same background, genetic 
susceptibility, and environmental interactions, anyone could suffer from drug abuse. 
We happen to be the lucky ones, and it is essential to see it that way. We must not view 
anyone as less than ourselves, as that is what creates a great divide in our culture. 
Personal Impact 
My research fits into the larger cultural realm because there is a serious lack of 
empathy for those struggling with mental disorders and addiction. As member of 
society, I believe it is important to not only inform anyone who has preconceived notions 
about addiction or mental disorders, but to personally help those struggling every day to 
fight addiction. As I constantly work to relieve some of the judgment and induce 
compassion on these struggling individuals, I know I need to touch these people's live 
personally. In the summer of 2017, I earned my COCA phase I licensure and was able 
to work at a partial hospitalization drug and alcohol recovery facility called Genesis life 
and recovery, in Hamilton Ohio. There, I assessed patients using Clinical Opiate 
Withdrawal scales (COWS) and Clinical Institute Withdrawal Assessment for Alcohol 
(CIWA). They were each given a number after hourly assessments and the doctor used 
this information to know when it was time to prescribe them medication. I had several 
intake duties that required me to assess patients over the phone in order to confirm that 
Genesis was the right place for them. I also administered drug urine screens and took 
vitals on a daily basis. Furthermore, I was able to sit in on group counseling sessions 
and help manage medications. This is where I really got to know the patients on a more 
personal level. 
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Acquiring my COCA phase I helped me to better unders'tanding addiction as 
disease, and not as a choice. It is something that takes over someone's body in pursuit 
of eliminating pain. It was common that most of these people had criminal records, not 
from physically harming others, but from theft, possession and use of drugs, and other 
violations. As an employee at a rehabilitation facility, I learned quickly the importance of 
seeing behind the lying, manipulative persona, and recognize that is not necessarily 
who they were as a person, it was their addiction. However, it was our job to recognize 
this in order to help them become productive additions to society. 
Before my internship at Genesis life and recovery, I placed much more blame on 
the drug abusers themselves for their current situation. It was fascinating for me to see 
the patterns of people who graduated compared to the ones who left voluntarily, and 
versus the ones dismissed by the facility. Commonly, successful ones were those who 
placed themselves in the program, as opposed to having an outside instigator such as 
friends, family members or legal enforcement. So, if these people have the willpower 
to place themselves in treatment, then why does everyone not simply do it? This 
only intensified my thoughts of attributing the cause of abuse to the person. It was only 
when I learned more about the background of these individuals that I began to express 
more understanding towards their situation. 
I worked with men from the ages of 18 to 50 who were more likely than not 
abused, neglected, and surrounded with drugs their entire lives. However, I also 
encountered patients, who came from financially stable famtlies. Most of these people 
grew up with a single parent or grandparent. A decent number came from great family 
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backgrounds, had a surgery, immediately became addicted to painkillers, and lost 
everything. Seeing this on a daily basis, really impacts a person's level of empathy. I 
cannot say for certain that if I had grown up or underwent some of their same 
circumstances that I would not have also turned out like them. This is not to say that 
these people should not take responsibility for their actions, but it is important to 
understand of this struggle, was not their fault. The summer of 2017 was so incredibly 
impactful on me; I knew I could not stop there. 
I have completed the steps to receive my COCA Phase II licensure. As my phase 
I licensure expires in one year, phase II will allow me to sustain my position as a COCA 
with two-year follow up examinations. With this, I have received another summer 
internship position at a different drug rehab facility in West Chester, Ohio called 
"Lumiere Healing Center." This is an in-patient facility that supports men and women 
through their drug-related illness by encompassing several aspects of treatment. This 
facility provides a safe place to live, around the clock healthcare, group and 
independent counseling , and medication- based treatments. I will be filling the role of a 
behavior therapist, where I help drug-addicted persons seek healthier behaviors in 
terms of their drug use. To assist these patients into being productive members of 
society, detoxification and medicated assisted treatment are just the first steps on the 
road to recovery. As discussed earlier, their brains have been permanently impacted by 
drug use, and an immediate fix of a drug is desired every day. Recovering drug-
addicted individuals must acquire the physical and' mental strength to avoid drug 
associated persons and environments. The passion I have for this type of work has 
arisen genuinely through my experiences and practices. As my college education has 
Main 25 
prepared me for a future career as a physician assistant, my impactful experiences 
surrounding the constant battle of drug abuse have instilled a greater sense of 
compassion as a hands-on caregiver. 
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